Citadel Advisors - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$167,520,000
+60.0%
3,848,409
+60.1%
0.04%
+95.5%
Q1 2022$104,701,000
-9.1%
2,403,621
-7.9%
0.02%
-4.3%
Q4 2021$115,130,000
+23.7%
2,610,635
+7.2%
0.02%
+15.0%
Q3 2021$93,086,000
+0.3%
2,436,166
+4.5%
0.02%
-4.8%
Q2 2021$92,791,000
+32.2%
2,330,261
+18.5%
0.02%
+23.5%
Q1 2021$70,183,000
+219.8%
1,966,443
+229.7%
0.02%
+183.3%
Q4 2020$21,949,000
-16.3%
596,416
-14.4%
0.01%
-25.0%
Q3 2020$26,232,000
+14.7%
696,925
+24.3%
0.01%
+14.3%
Q2 2020$22,872,000
-30.5%
560,733
-35.4%
0.01%
-50.0%
Q1 2020$32,913,000
+61.3%
868,652
+100.0%
0.01%
+55.6%
Q4 2019$20,410,000
-14.7%
434,358
-22.6%
0.01%
-18.2%
Q3 2019$23,941,000
+15.2%
560,931
+8.1%
0.01%
+22.2%
Q2 2019$20,775,000
-47.2%
519,110
-44.9%
0.01%
-55.0%
Q1 2019$39,353,000
+38.6%
941,693
+26.8%
0.02%
+33.3%
Q4 2018$28,384,000
-37.2%
742,836
-34.0%
0.02%
-25.0%
Q3 2018$45,230,000
+115.8%
1,125,958
+116.5%
0.02%
+81.8%
Q2 2018$20,962,000
-7.8%
520,019
-10.6%
0.01%
-8.3%
Q1 2018$22,727,000
-31.6%
581,694
-37.9%
0.01%
-40.0%
Q4 2017$33,221,000
+1.5%
936,598
+16.2%
0.02%
-23.1%
Q3 2017$32,726,000
-5.3%
806,058
+0.6%
0.03%
-10.3%
Q2 2017$34,558,000
-13.1%
801,424
-15.0%
0.03%
-21.6%
Q1 2017$39,764,000
+100.0%
943,156
+82.7%
0.04%
+85.0%
Q4 2016$19,878,000
+245.0%
516,175
+286.4%
0.02%
+233.3%
Q3 2016$5,762,000
+187.0%
133,600
+168.4%
0.01%
+200.0%
Q4 2015$2,008,000
-40.7%
49,784
-43.5%
0.00%
-33.3%
Q3 2015$3,387,000
-86.9%
88,100
-85.8%
0.00%
-86.4%
Q2 2015$25,784,000
+1949.6%
619,078
+2170.4%
0.02%
+2100.0%
Q1 2015$1,258,000
-58.8%
27,267
-61.8%
0.00%
-66.7%
Q4 2014$3,053,000
-87.6%
71,432
-86.6%
0.00%
-88.5%
Q3 2014$24,533,000
+635.0%
533,654
+754.9%
0.03%
+550.0%
Q2 2014$3,338,000
-33.6%
62,424
-33.7%
0.00%
-33.3%
Q1 2014$5,028,000
+39.6%
94,099
+39.5%
0.01%
+20.0%
Q4 2013$3,601,000
-6.5%
67,443
-12.1%
0.01%
-16.7%
Q3 2013$3,850,000
-62.9%
76,757
-63.0%
0.01%
-66.7%
Q2 2013$10,366,000207,4480.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2022
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders